Fulcrum Therapeutics
FULC
#8396
Rank
C$0.40 B
Marketcap
C$5.29
Share price
-0.54%
Change (1 day)
-66.76%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2026 (TTM): C-$1.69

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is C-$1.74. In 2025 the company made an earnings per share (EPS) of C-$1.69 a decrease over its 2024 EPS that were of C-$0.29.

EPS history for Fulcrum Therapeutics from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.69-0.33%
2025C-$1.69490%
2024C-$0.29-87.34%
2023C-$2.27-36.29%
2022C-$3.568.3%
2021C-$3.28-18.51%
2020C-$4.03-31.36%
2019C-$5.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.94 11.57%๐Ÿ‡บ๐Ÿ‡ธ USA